+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GODAVARI

Godavari Drugs Share Price

 

 

Godavari Drugs live price: ₹116.

Godavari Drugs Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹116.70
  • 100 DMA₹106.56
  • 200 DMA₹98.94

Godavari Drugs Chart

Investment Returns

  • Over 1 Month -10.87%
  • Over 3 Month + 39.94%
  • Over 6 Month + 62.08%
  • Over 1 Year + 19.98%

Smart Investing Starts Here Start SIP with Godavari Drugs for Steady Growth!

Invest Now

Godavari Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Godavari Drugs Financials

Godavari Drugs Technicals

EMA & SMA

Current Price
₹116.00
-6.1 (-5%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹124.30
  • 50 Day
  • ₹116.70
  • 100 Day
  • ₹106.60
  • 200 Day
  • ₹98.90

Resistance and Support

123.35 Pivot Speed
  • R3 128.65
  • R2 127.30
  • R1 124.70
  • S1 120.75
  • S2 119.40
  • S3 116.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Godavari Biorefineries Ltd has an operating revenue of Rs. 1,987.94 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 42%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -19% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 13 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 42 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Godavari Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-27 Audited Results
2026-02-11 Quarterly Results
2026-01-15 Preferential issue of shares
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results & A.G.M.

Godavari Drugs Shareholding Pattern

63.31%
9.53%
0.98%
21.2%
4.98%

Godavari Drugs FAQs

Godavari Drugs share price is ₹116 As on 11 June, 2026 | 17:22

The Market Cap of Godavari Drugs is ₹117.5 Cr As on 11 June, 2026 | 17:22

The P/E ratio of Godavari Drugs is 28.7 As on 11 June, 2026 | 17:22

The PB ratio of Godavari Drugs is 1.5 As on 11 June, 2026 | 17:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23